mhurhangee/ep-ind-claims huggingface dataset:
A compound of Formula, having the following structure wherein, R 1, R 2, and R 3 are independently selected from C 1 -C 3 alkyl; m, m' and m" are integers, each independently selected from 3 to 100; n, n', and n" are integers, each independently selected from 1 to 100. R 1, R 2, and R 3 are independently selected from C 1 -C 3 alkyl; m, m' and m" are integers, each independently selected from 3 to 100; n, n', and n" are integers, each independently selected from 1 to 100.
A hearing protection device comprising: a first earmuff connected to a second earmuff by a connector, wherein each of the first and second earmuffs are configured to receive an ambient sound and provide a dampened ambient sound to a wearer; and a cable, with a cable length, that extends from the first earmuff to the second earmuff, wherein the cable is coupled to the connector by a connection assembly and wherein the connection assembly comprises a plurality of connection mechanisms arranged in a connection plan;. wherein the connection plan comprises the plurality of connection mechanisms arranged alternatingly on a first side of the connector and a second side of the connector. a first earmuff connected to a second earmuff by a connector, wherein each of the first and second earmuffs are configured to receive an ambient sound and provide a dampened ambient sound to a wearer; and a cable, with a cable length, that extends from the first earmuff to the second earmuff, wherein the cable is coupled to the connector by a connection assembly and wherein the connection assembly comprises a plurality of connection mechanisms arranged in a connection plan;. wherein the connection plan comprises the plurality of connection mechanisms arranged alternatingly on a first side of the connector and a second side of the connector.
Micromechanical component having a substrate and a structure which is movable with respect to the substrate, the movable structure having a starting layer and a layer grown on the starting layer, characterized in that the movable structure has at least one further starting layer and one further layer grown on the further starting layer, the further starting layers (4', 4") and the further layers (5', 5") comprising polycrystalline silicon, or the substrate, the further starting layers (4', 4") and/or the further layers (5', 5") comprising monocrystalline silicon.
A steering control device configured to control a steering system including a switching device (14, 66) that is switched between a transmission state and a cutoff state, the transmission state being a state where power is transmitted from a steering wheel to steered wheels, and the cutoff state being a state where transmission of the power from the steering wheel to the steered wheels is cut off; a steering-side actuator configured to apply a steering reaction force to the steering wheel in the cutoff state; and a turning-side actuator configured to turn the steered wheels, the steering control device comprising a controller configured to execute: turning processing of controlling a controlled variable to a command value corresponding to an operation of the steering wheel by controlling the turning-side actuator in the cutoff state, characterized in that the controlled variable is at least one of a turning angle of the steered wheels and a turning angle rate that is a changing rate of the turning angle; and transmission switching processing controls the switching device (14, 66) such that the switching device (14, 66) is switched from the cutoff state to the transmission state on condition that an absolute value of a difference between the controlled variable and the command value continues to be equal to or larger than a threshold when the turning processing is executed.
A method implemented at a base station, comprising: transmitting a positioning reference signal; receiving a transmission leakage signal and a reflection signal of the positioning reference signal; determining whether there exists an obstacle based on the reflection signal; and determining position information of the obstacle based on the transmission leakage signal and the reflection signal. transmitting a positioning reference signal; receiving a transmission leakage signal and a reflection signal of the positioning reference signal; determining whether there exists an obstacle based on the reflection signal; and determining position information of the obstacle based on the transmission leakage signal and the reflection signal.
A cable sealing device (100, 200, 300) for a port structure in a telecommunication terminal, enclosure or bulkhead, the sealing device comprising: a unibody construction comprising a rigid body portion (110, 210, 310), the rigid portion having a generally cylindrical shape that includes an interior passageway extending from a first end to a second end of the rigid body portion; and an elastomeric body portion (150, 250, 350) extending from an end of the rigid body portion, the elastomeric body portion comprising a front end having an exterior sealing sleeve that is formed over the second end of rigid body portion, and a closed end disposed opposite the open end, wherein the closed end includes a removable portion, characterised in that the elastomeric body portion further comprises an elastomeric tongue extending from the front end of the elastomeric body portion and through the interior passageway in the rigid body portion, and wherein the elastomeric tongue has an exposed surface and wherein the exposed surface provides an anti-slip or friction surface that improves the retention of a cable that is secured to the cable retention device. a unibody construction comprising a rigid body portion (110, 210, 310), the rigid portion having a generally cylindrical shape that includes an interior passageway extending from a first end to a second end of the rigid body portion; and an elastomeric body portion (150, 250, 350) extending from an end of the rigid body portion, the elastomeric body portion comprising a front end having an exterior sealing sleeve that is formed over the second end of rigid body portion, and a closed end disposed opposite the open end, wherein the closed end includes a removable portion, characterised in that the elastomeric body portion further comprises an elastomeric tongue extending from the front end of the elastomeric body portion and through the interior passageway in the rigid body portion, and wherein the elastomeric tongue has an exposed surface and wherein the exposed surface provides an anti-slip or friction surface that improves the retention of a cable that is secured to the cable retention device.
A medical device, comprising: a sensing circuit configured to: sense a cardiac electrical signal comprising T-waves attendant to ventricular myocardial repolarizations; and sense R-waves attendant to ventricular myocardial depolarizations from the cardiac electrical signal; a control circuit configured to: detect a first T-wave template condition associated with non-pathological changes in T-wave morphology; generate a first T-wave template from at least one T-wave sensed by the sensing circuit during the detected first T-wave template condition; after generating the first T-wave template, acquire a first T-wave signal from the cardiac electrical signal sensed by the sensing circuit; compare the acquired first T-wave signal to the first T-wave template; determine that the first T-wave signal does not match the first T-wave template; detect a pathological event in response to at least the acquired first T-wave signal not matching the first T-wave template; and adjust a ventricular sensing control parameter used to sense the R-waves in response to detecting the pathological event. a sensing circuit configured to: sense a cardiac electrical signal comprising T-waves attendant to ventricular myocardial repolarizations; and sense R-waves attendant to ventricular myocardial depolarizations from the cardiac electrical signal; sense a cardiac electrical signal comprising T-waves attendant to ventricular myocardial repolarizations; and sense R-waves attendant to ventricular myocardial depolarizations from the cardiac electrical signal; a control circuit configured to: detect a first T-wave template condition associated with non-pathological changes in T-wave morphology; generate a first T-wave template from at least one T-wave sensed by the sensing circuit during the detected first T-wave template condition; after generating the first T-wave template, acquire a first T-wave signal from the cardiac electrical signal sensed by the sensing circuit; compare the acquired first T-wave signal to the first T-wave template; determine that the first T-wave signal does not match the first T-wave template; detect a pathological event in response to at least the acquired first T-wave signal not matching the first T-wave template; and adjust a ventricular sensing control parameter used to sense the R-waves in response to detecting the pathological event. detect a first T-wave template condition associated with non-pathological changes in T-wave morphology; generate a first T-wave template from at least one T-wave sensed by the sensing circuit during the detected first T-wave template condition; after generating the first T-wave template, acquire a first T-wave signal from the cardiac electrical signal sensed by the sensing circuit; compare the acquired first T-wave signal to the first T-wave template; determine that the first T-wave signal does not match the first T-wave template; detect a pathological event in response to at least the acquired first T-wave signal not matching the first T-wave template; and adjust a ventricular sensing control parameter used to sense the R-waves in response to detecting the pathological event.
Heat exchange plate for a fully welded compact plate heat exchanger, comprising - a thermally active surface with a profile; - a first and a second through-opening (8, 9) for a second flowing medium which are arranged above the thermally active surface; - a peripheral profile-free welding edge, wherein - the through-openings (8, 9) are arranged in a first and a second plate portion (12, 12a), and the plate portions (12, 12a) are arranged so as to be diagonally offset at opposite end faces of the thermally active surface; and - the peripheral profile-free welding edge semicircularly encloses the through-openings (8, 9) in the region of the plate portions (12, 12a) and adjoins said through-openings in the region of the transition (6, 6a) from the plate portion (12, 12a) to the end face of the thermally active surface with a quarter-circle shape having the same radius, characterized in that the through-openings (8, 9) are arranged in the flow region for a first flowing medium. - a thermally active surface with a profile; - a first and a second through-opening (8, 9) for a second flowing medium which are arranged above the thermally active surface; - a peripheral profile-free welding edge, - the through-openings (8, 9) are arranged in a first and a second plate portion (12, 12a), and the plate portions (12, 12a) are arranged so as to be diagonally offset at opposite end faces of the thermally active surface; and - the peripheral profile-free welding edge semicircularly encloses the through-openings (8, 9) in the region of the plate portions (12, 12a) and adjoins said through-openings in the region of the transition (6, 6a) from the plate portion (12, 12a) to the end face of the thermally active surface with a quarter-circle shape having the same radius,
A system for segmenting an object in a medical image comprising: - a first adapter for adapting a first deformable model for segmenting the object to the medical image; - an analyzer for extracting a feature from the image based on a steered region growing process which growth space is limited based on marked triangles of the mesh of the first deformable model and the center of the adapted first deformable model; - a selector for selecting a second deformable model for segmenting the object based on the feature extracted from the medical image, wherein the second deformable model comprises additional detail of the object; - an initializer for initializing the second deformable model based on the adapted first deformable model and/or the feature extracted from the medical image; and - a second adapter for adapting the initialized second deformable model to the medical image. - a first adapter for adapting a first deformable model for segmenting the object to the medical image; - an analyzer for extracting a feature from the image based on a steered region growing process which growth space is limited based on marked triangles of the mesh of the first deformable model and the center of the adapted first deformable model; - a selector for selecting a second deformable model for segmenting the object based on the feature extracted from the medical image, wherein the second deformable model comprises additional detail of the object; - an initializer for initializing the second deformable model based on the adapted first deformable model and/or the feature extracted from the medical image; and - a second adapter for adapting the initialized second deformable model to the medical image.
A method for predicting the rate of progression or improvement and/or the duration of a condition associated with tissue degeneration and/or pain in a subject, comprising imaging a region of a subject's body; detecting one or more biomarkers within the imaged region, selected from the group consisting of pH, glycosaminoglycan concentration, glucose concentration, and lactate concentration; and predicting the rate of progression or improvement and/or the duration of the condition by comparing measurements of one or more biomarkers detected within the imaged region to previous measurements of the same one or more biomarkers detected within the imaged region, wherein the biomarkers are detected by chemical exchange saturation transfer (CEST) imaging. imaging a region of a subject's body; detecting one or more biomarkers within the imaged region, selected from the group consisting of pH, glycosaminoglycan concentration, glucose concentration, and lactate concentration; and predicting the rate of progression or improvement and/or the duration of the condition by comparing measurements of one or more biomarkers detected within the imaged region to previous measurements of the same one or more biomarkers detected within the imaged region, wherein the biomarkers are detected by chemical exchange saturation transfer (CEST) imaging.
A system-on-module for controlling an unmanned vehicle, comprising: a circuit board (120, 200); a first processing system in operative communication with the circuit board (120, 200), the first processing system including one or more first processing units and a volatile programmable logic array, the first processing system configured to execute a first process for the UV; and a second processing system in operative communication with the circuit board (120, 200), the second processing system including one or more second processing units and a non-volatile programmable logic array, the non-volatile programmable logic array configured to monitor execution of the first process by the first processing system, the non-volatile programmable logic array being further configured to determine whether an output associated with execution of the first process is valid and to initiate a first control action for the UV based on a valid output associated with execution of the first process and a second control action for the UV based on an invalid output associated with execution of the first process, the first control action and the second control action being different. a circuit board (120, 200); a first processing system in operative communication with the circuit board (120, 200), the first processing system including one or more first processing units and a volatile programmable logic array, the first processing system configured to execute a first process for the UV; and a second processing system in operative communication with the circuit board (120, 200), the second processing system including one or more second processing units and a non-volatile programmable logic array, the non-volatile programmable logic array configured to monitor execution of the first process by the first processing system, the non-volatile programmable logic array being further configured to determine whether an output associated with execution of the first process is valid and to initiate a first control action for the UV based on a valid output associated with execution of the first process and a second control action for the UV based on an invalid output associated with execution of the first process, the first control action and the second control action being different.
An electronic balance comprising: a balance main body configured to hold a weighing mechanism connected to a weighing pan; and a windshield including a frame and a door disposed slidably on the frame, and configured to form a weighing chamber by covering the weighing pan, characterized in that the windshield includes inside an air cylinder connected to the door and configured to open and close the door, and an air pump (62A, 62B) configured to drive the air cylinder, and is configured to be detachable from the balance main body. a balance main body configured to hold a weighing mechanism connected to a weighing pan; and a windshield including a frame and a door disposed slidably on the frame, and configured to form a weighing chamber by covering the weighing pan, characterized in that the windshield includes inside an air cylinder connected to the door and configured to open and close the door, and an air pump (62A, 62B) configured to drive the air cylinder, and is configured to be detachable from the balance main body.
A process comprising: (i) first, contacting a textile with an aqueous solution comprising a cationic hydroxyethylcellulose polymer to form a modified textile component; (ii) subsequently, impregnating the modified textile component with an aqueous polyurethane dispersion externally stabilized with an anionic surfactant; and (iii) precipitating the polyurethane in the modified textile component. (i) first, contacting a textile with an aqueous solution comprising a cationic hydroxyethylcellulose polymer to form a modified textile component; (ii) subsequently, impregnating the modified textile component with an aqueous polyurethane dispersion externally stabilized with an anionic surfactant; and (iii) precipitating the polyurethane in the modified textile component.
Spun poly(2,5-benzimidazole) (ABPBI) fibers characterized by having the following properties: a. filaments in the range of 1.67 dtex (1.5 denier) to 13.33 dtex (12.0 denier); b. tenacity in the range of 2.21 cN/dtex (2.5 grams per denier) to 3.53 cN/dtex (4.0 grams per denier); c. break strength in the range of 3.92 cN (4.0 gmf) to 14.71 cN (15 gmf); and d. elogantion at break in the range of 15 - 25% a. filaments in the range of 1.67 dtex (1.5 denier) to 13.33 dtex (12.0 denier); b. tenacity in the range of 2.21 cN/dtex (2.5 grams per denier) to 3.53 cN/dtex (4.0 grams per denier); c. break strength in the range of 3.92 cN (4.0 gmf) to 14.71 cN (15 gmf); and d. elogantion at break in the range of 15 - 25%
Folding machine for blanks for forming containers comprising at least one base and four sides, the blanks comprising at least one base portion and side flaps, the machine comprising at least: - one shaping cavity comprising a first level and a second level; - a blank conveyor which is capable of conveying the blanks one by one as far as a first level of the cavity; - a piston which is mounted so as to be movable in terms of translation inside the cavity and means for driving the piston between at least the first level and the second level of the cavity; - lower stops for keeping the base portion located at the second level of the cavity, the lower stops being mounted so as to be movable along the shaping cavity in order to define the second level; - means for driving the lower stops between a holding position in which it protrudes inside the cavity and an ejection position in which they are spaced apart outside the cavity; - shaping guides which are placed at the periphery of the cavity and which able to act on the side flaps in order to shape the container by means of folding from the blank when the piston moves from the first level to the second level of the cavity; characterised in that the means for driving the piston are configured to move the lower stops along the shaping cavity in order to define the second level. - one shaping cavity comprising a first level and a second level; - a blank conveyor which is capable of conveying the blanks one by one as far as a first level of the cavity; - a piston which is mounted so as to be movable in terms of translation inside the cavity and means for driving the piston between at least the first level and the second level of the cavity; - lower stops for keeping the base portion located at the second level of the cavity, the lower stops being mounted so as to be movable along the shaping cavity in order to define the second level; - means for driving the lower stops between a holding position in which it protrudes inside the cavity and an ejection position in which they are spaced apart outside the cavity; - shaping guides which are placed at the periphery of the cavity and which able to act on the side flaps in order to shape the container by means of folding from the blank when the piston moves from the first level to the second level of the cavity;
A method for determining prostate carcinoma, comprising: measuring an amount of a free prostate specific antigen and an amount of a free PSA having an α(2,3) glycan, the free PSA having an α(2,3) glycan being a free prostate specific antigen having a glycan in which a terminal sialic acid residue of the glycan is α(2,3)-linked to a second galactose residue from a terminal of the glycan, in a sample derived from a subject; obtaining a ratio 1 between the amount of the free prostate specific antigen and the amount of the free PSA having an α(2,3) glycan; obtaining a ratio 2 between the ratio 1 and a volume of the prostate of the subject; and determining prostate carcinoma based on the obtained ratio 2. measuring an amount of a free prostate specific antigen and an amount of a free PSA having an α(2,3) glycan, the free PSA having an α(2,3) glycan being a free prostate specific antigen having a glycan in which a terminal sialic acid residue of the glycan is α(2,3)-linked to a second galactose residue from a terminal of the glycan, in a sample derived from a subject; obtaining a ratio 1 between the amount of the free prostate specific antigen and the amount of the free PSA having an α(2,3) glycan; obtaining a ratio 2 between the ratio 1 and a volume of the prostate of the subject; and determining prostate carcinoma based on the obtained ratio 2.